Accendra Health Inc
ACHNYSECIK 75252Consumer discretionaryFiscal year ends Dec 31
Reports and events: 332 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:15 ET | DEF 14A | Proxy statementPeriod 2026-12-01 | 0001104659-26-120208 |
| 2026-10-0916:10 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-115043 |
| 2026-09-2817:06 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-111408 |
| 2026-09-1706:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-108405 |
| 2026-08-1706:42 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-097517 |
| 2026-08-1016:15 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-093381 |
| 2026-08-1011:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-093177 |
| 2026-08-1006:50 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-092999 |
| 2026-08-1006:36 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-092973 |
| 2026-06-2516:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-282808 |
| 2026-06-1516:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-271115 |
| 2026-05-2216:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-236869 |
| 2026-05-1508:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-26-061888 |
| 2026-05-1111:59 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-058465 |
| 2026-05-1106:50 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-215654 |
| 2026-05-1106:35 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-058226 |
| 2026-04-0206:25 ET | DEF 14A | Proxy statementPeriod 2026-05-14 | 0001104659-26-038823 |
| 2026-02-2016:19 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-018169 |
| 2026-02-1916:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-017541 |
| 2026-01-0516:05 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001104659-26-000614 |
| 2025-12-3116:15 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-338325 |
| 2025-12-1816:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-122553 |
| 2025-12-0806:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001193125-25-310528 |
| 2025-12-0207:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-304500 |
| 2025-11-1416:15 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-25-282986 |
| 2025-10-3117:35 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-104506 |
| 2025-10-3016:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-104379 |
| 2025-10-0716:48 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-233577 |
| 2025-09-1906:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-208137 |
| 2025-08-1116:40 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011059 |
| 2025-08-1106:41 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-177426 |
| 2025-06-0616:30 ET | 8-K | 2.04 Item not in the standard list | 0001193125-25-137107 |
| 2025-06-0509:12 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-135378 |
| 2025-05-1608:30 ET | 8-K | 5.07 Shareholder vote results | 0001558370-25-007927 |
| 2025-05-0816:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-006964 |
| 2025-05-0806:35 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-006844 |
| 2025-04-0417:24 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-073544 |
| 2025-04-0406:05 ET | DEF 14A | Proxy statementPeriod 2025-05-15 | 0001193125-25-072752 |
| 2025-04-0217:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-071448 |
| 2025-03-2616:49 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-064131 |
| 2025-03-2006:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-058292 |
| 2025-02-2816:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-001940 |
| 2025-02-2806:35 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-001879 |
| 2025-02-0306:49 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-018849 |
| 2024-11-0516:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001558370-24-014426 |
| 2024-11-0416:06 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014255 |
| 2024-11-0406:35 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-014177 |
| 2024-10-2216:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-241069 |
| 2024-10-1507:01 ET | 8-K | 8.01 Other events | 0001193125-24-237188 |
| 2024-09-2307:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-223254 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:18 ET. Listed shows no prices and gives no investment advice.